GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,450 | +1.7% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,426 | +14160.0% | 40 | -85.9% | 0.00% | -80.0% |
| Q1 2023 | $10 | +11.1% | 283 | +16.5% | 0.01% | +25.0% |
| Q4 2022 | $9 | -99.9% | 243 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $7,000 | -53.3% | 243 | -69.8% | 0.01% | 0.0% |
| Q2 2022 | $15,000 | -16.7% | 804 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $18,000 | -10.0% | 804 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $20,000 | -16.7% | 804 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $24,000 | +100.0% | 804 | +164.5% | 0.01% | +83.3% |
| Q2 2021 | $12,000 | +9.1% | 304 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $11,000 | 0.0% | 304 | +1.3% | 0.01% | 0.0% |
| Q4 2020 | $11,000 | -69.4% | 300 | -68.4% | 0.01% | -75.0% |
| Q3 2020 | $36,000 | +33.3% | 950 | +46.2% | 0.02% | +17.6% |
| Q2 2020 | $27,000 | -12.9% | 650 | 0.0% | 0.02% | -15.0% |
| Q4 2019 | $31,000 | – | 650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |